Author

Stéphane Paul 1

1 university of saint etienne

: THERAPEUTIC DRUG MONITORING OF INFLIXIMAB AND MUCOSAL HEALING IN INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE STUDY

Stéphane Paul, hubert marotte, Emilie Del Tedesco, Laurent Peyrin-Biroulet, Xavier Roblin

ANTI-USTEKINUMAB ANTIBODIES USING A DRUG TOLERANT ASSAY IS THE ONLY PREDICTIVE FACTOR OF CLINICAL REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENT UNDER USTEKINUMAB

Narjous CHAWKI, Mohammad CHAWKI, Pierre Cixous, Pauline Veyrard, Anne Berger, Jean Marc Phelip, Stéphane Paul, Xavier Roblin

ASSOCIATION BETWEEN THIOPURINES METABOLITES LEVELS AND CLINICAL REMISSION IN IBD PATIENTS : AN UPDATED META-ANALYSIS

amelie moreau, silvy laporte, Emilie Del Tedesco, Stéphane Paul, Jean Marc Phelip, Laurent Peyrin-Biroulet, Xavier Roblin

AZATHIOPRINE DOSE REDUCTION  INFLAMMATORY BOWEL DISEASE PATIENTS ON COMBINATION THERAPY: A PROSPECTIVE STUDY

Emilie Del Tedesco, Stéphane Paul, hubert marotte, Nicolas Williet, Jean Marc Phelip, Laurent Peyrin-Biroulet, Jean-Frederic Colombel, Xavier Roblin

DEVELOPMENT OF A NEW SCORE PREDICTIVE OF SUSTAINED CLINICAL REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE UNDER INFLIXIMAB-AZATHIOPRINE COMBOTHERAPY.

Baptiste Sivard, Nicolas Williet, Jean-Marc Phelip, Emilie Del Tedesco, Stéphane Paul, Xavier Roblin

DEVELOPMENT OF AN ALGORITHM INCORPORATING PHARMACOKINETICS OF ADALIMUMAB IN INFLAMMATORY BOWEL DISEASES

Xavier Roblin, Melanie Rinaudo, Emilie Del Tedesco, Laurent Biroulet, Stéphane Paul

EARLY DETECTION OF ANTI-DRUG-ANTIBODIES USING DRUG-TOLERANT ASSAY WITHIN THE INDUCTION PHASE AT WEEK 2 PREDICTS THE LOSS OF CLINICAL RESPONSE TO ANTI-TNF IN INFLAMMATORY BOWEL DISEASE PATIENTS

Quentin Tournier, Stéphane Paul, Nicolas Williet, Anne Emmanuelle Berger, Pauline Veyrard, Gilles Boschetti, J. Marc Phelip, Bernard Flourie, Stéphane Nancey, Xavier Roblin

ENRICHMENT OF CIRCULATING DOUBLE POSITIVE INTERLEUKIN-17 PRODUCING FOXP3+ CD4+ T CELL SUBSETS ARE ASSOCIATED WITH A HIGHER RISK OF FURTHER RELAPSE IN CROHN’S DISEASE IN REMISSION: AN OBSERVATIONAL, PROSPECTIVE MULTICENTER STUDY

Gilles Boschetti, Bernard Flourie, Xavier Roblin, Stéphane Paul, Jacques Bienvenu, Gilles Bommelaer, Anthony Buisson, Emilie Del Tedesco, Cendrine Josson, Stéphane Legastelois, Stéphane Nancey

EVALUATION OF LISA-TRACKER IMMUNOASSAY INFLIXIMAB AND ANTI-INFLIXIMAB FOR THE THERAPEUTIC DRUG MONITORING OF SB2.

Anne-Emmanuelle Berger, Alice Haccourt, Joseph Salameh, Xavier Roblin, Stéphane Paul

FAECAL CALPROTECTIN MEASUREMENT AND INFLIXIMAB TROUGH LEVELS PREDICT THERAPEUTIC EVOLUTION CD PATIENTS IN CLINICAL REMISSION.

Xavier Roblin, gerard duru, lea clavel, Emilie Del Tedesco, Jean Marc Phelip, Laurent Biroulet, Stéphane Paul

Item 1 - 10 / 29
1
2 3